1. Home
  2. OPXS vs ANIX Comparison

OPXS vs ANIX Comparison

Compare OPXS & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Optex Systems Holdings Inc.

OPXS

Optex Systems Holdings Inc.

HOLD

Current Price

$13.97

Market Cap

90.5M

Sector

Technology

ML Signal

HOLD

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$3.14

Market Cap

88.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPXS
ANIX
Founded
1987
1982
Country
United States
United States
Employees
72
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
90.5M
88.8M
IPO Year
2009
2013

Fundamental Metrics

Financial Performance
Metric
OPXS
ANIX
Price
$13.97
$3.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$16.10
$8.67
AVG Volume (30 Days)
45.4K
223.3K
Earning Date
05-11-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
34.55
12.82
EPS
0.23
N/A
Revenue
$24,530,000.00
$210,000.00
Revenue This Year
$39.17
N/A
Revenue Next Year
$0.53
N/A
P/E Ratio
$61.00
N/A
Revenue Growth
17.63
N/A
52 Week Low
$9.74
$2.32
52 Week High
$17.76
$5.46

Technical Indicators

Market Signals
Indicator
OPXS
ANIX
Relative Strength Index (RSI) 60.63 64.53
Support Level $12.46 $2.90
Resistance Level $13.68 $3.58
Average True Range (ATR) 0.78 0.25
MACD 0.08 0.05
Stochastic Oscillator 78.05 87.80

Price Performance

Historical Comparison
OPXS
ANIX

About OPXS Optex Systems Holdings Inc.

Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson, Applied Optics Center Dallas, and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor, and others.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Share on Social Networks: